Search
forResearch 10 of 1000+
- Reflecting on the intersectionality of lived experiences of dermatological diseases and the WHO Framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions
- An occupational perspective of the lived experience of individuals with Alopecia Areata: A scoping review
- Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent
- Hodgkin′s lymphoma presenting as alopecia
- Clinical Quiz
- A Rare association of Mauriac syndrome and Van-Wyk Grumbach syndrome found in a young Saudi girl with poorly controlled type 1 Diabetes and Hypothyroidism: A Case Report and Brief literature review
- [A systemic-like disease: chronic vitamin A poisoning].
- STUDIED ON TOXICITY OF HYDROCORTISONE 17-BUTYRATE 21-PROPIONATE : 6. Subacute Toxicity in Dogs by Percutaneous Adminisration
- Transmasculine Hormone Therapy
- Health consequences of anabolic steroids: a sexual-medicine perspective
Learn 2 of 11
All learn results →Community 10 of 86
- Deciding Between Oral or Topical Min and Fin with Fatty Liver
- Increased liver enzymes from hairloss medications.
- Can liver problems be associated with response to the oral minoxidil?
- Sensitive liver, topical fin safe to try?
- Attention Finasteride / Dutasteride and Your liver
- liver problem from finasteride/dutasteride
- 28M: Can I Combine Oral and Topical Finasteride with Elevated Liver Enzymes?
- Could fatty liver(other issues related to it..)play a role in Dupa/Aga?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Finally live! alcohol-free, propylene glycol–free topical finasteride foam